ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BGLC BioNexus Gene Lab Corporation

0.6217
-0.0413 (-6.23%)
Apr 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 132,142
Bid Price 0.62
Ask Price 0.6551
News -
Day High 0.75

Low
0.31

52 Week Range

High
9.49

Day Low 0.6216
Company Name Stock Ticker Symbol Market Type
BioNexus Gene Lab Corporation BGLC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0413 -6.23% 0.6217 16:38:05
Open Price Low Price High Price Close Price Prev Close
0.6549 0.6216 0.75 0.6217 0.663
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
358 132,142 $ 0.6576066 $ 86,897 - 0.31 - 9.49
Last Trade Time Type Quantity Stock Price Currency
17:55:06 76 $ 0.62 USD

BioNexus Gene Lab Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
10.95M 17.67M - 11.11M -356k -0.02 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioNexus Gene Lab News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BGLC Message Board. Create One! See More Posts on BGLC Message Board See More Message Board Posts

Historical BGLC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.62270.750.620.650552934,357-0.001-0.16%
1 Month0.71930.830.58790.66382985,950-0.0976-13.57%
3 Months0.5213.390.40041.451,585,2060.100719.33%
6 Months0.653.390.311.131,785,922-0.0283-4.35%
1 Year3.509.490.311.502,149,598-2.88-82.24%
3 Years3.509.490.311.502,149,598-2.88-82.24%
5 Years3.509.490.311.502,149,598-2.88-82.24%

BioNexus Gene Lab Description

BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.

Your Recent History

Delayed Upgrade Clock